Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
Patrick N. A. Harris(The University of Queensland), David L. Paterson(The University of Queensland), John F. McNamara(Prince Charles Hospital), Riccardo Utili(University of Campania "Luigi Vanvitelli"), Guy Thwaites(Oxford University Clinical Research Unit), Keith S. Kaye(Johnson University), Joshua S. Davis(John Hunter Hospital), Allen Cheng(Australian Regenerative Medicine Institute), Leonard Leibovici(Tel Aviv University), David Chien Lye(Agency for Science, Technology and Research), Benjamin A. Rogers(Monash University), Vance G. Fowler(Duke University), Louis Bernard(Université Paris Cité), Martin Llewelyn(Brighton and Sussex Medical School), Jesús Rodríguez‐Baño(Hospital Universitario Virgen Macarena), Jeffrey Lipman(The University of Queensland), Mical Paul(Technion – Israel Institute of Technology), Steven Y. C. Tong(The Royal Melbourne Hospital), Visanu Thamlikitkul(Siriraj Hospital), Harald Seifert(German Center for Infection Research), L. Silvia Muñoz-Price(Emerald Coast Science Center), Anton Y. Peleg(Discovery Institute), John Turnidge(The University of Adelaide), S. A. R. Webb(The University of Western Australia), Yohei Doi(Fujita Health University)
Cited by 83
Related Papers
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
|Clinical Microbiology Reviews|2015|5.1k
Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
|Nature Reviews Microbiology|2019|2k